Pneumococcal conjugate second or third-dose vaccines (PCVc) in South-East Asia (WHO region)
South-East Asia (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc) was 92.0% in 2025. ◆ Volatile
Latest (2025)
92.0%
Change on year
up 2.2%
Rank
1st
of 11 groups
All-time high
92.0%
in 2025
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in South-East Asia (WHO region), 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
South-East Asia (WHO region) recorded 92.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 2.2% on the previous year and up 1,740.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in South-East Asia (WHO region) peaked at 92.0% in 2025 and was at its lowest, 0.0%, in 2008.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 5.0% | — |
| 2016 | 11.0% | +120.0% |
| 2017 | 15.0% | +36.4% |
| 2018 | 20.0% | +33.3% |
| 2019 | 27.0% | +35.0% |
| 2020 | 32.0% | +18.5% |
| 2021 | 34.0% | +6.2% |
| 2022 | 67.0% | +97.1% |
| 2023 | 81.0% | +20.9% |
| 2024 | 90.0% | +11.1% |
| 2025 | 92.0% | +2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 7.8% | 0.0% | 27.0% | 10 |
| 2020s | 66.0% | 32.0% | 92.0% | 6 |
Countries ranked near South-East Asia (WHO region)
- 1 Cook Islands 99.0% compare
- 1 Hungary 99.0% compare
- 1 Oman 99.0% compare
- 1 Bahrain 99.0% compare
- 1 Seychelles 99.0% compare
- 1 Bhutan 99.0% compare
- 1 Cuba 99.0% compare
- 1 Palestine, State of 99.0% compare
- 1 Uzbekistan 99.0% compare
- 1 Guyana 99.0% compare
More health data for South-East Asia (WHO region)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 17.14 % change on previous year (2025)
- Diphtheria - number of reported cases 3,416 (2025)
- Measles - number of reported cases 19,075 (2025)
- Total tetanus - number of reported cases 164 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in South-East Asia (WHO region)?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in South-East Asia (WHO region) was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in South-East Asia (WHO region)?
- The highest recorded value was 92.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in South-East Asia (WHO region)?
- The lowest recorded value was 0.0% in 2008.
- How does South-East Asia (WHO region) rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- South-East Asia (WHO region) ranks 1st out of 11 groups with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 1,740.0%. The long-run trend across the full record is volatile.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).